PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Singapore scientists uncover gene associated with an aggressive breast cancer

Over-expressed gene in triple negative breast cancer offers new diagnostics for risk assessment

2014-12-01
(Press-News.org) Singapore--Scientists at A*STAR's Genome Institute of Singapore (GIS), in collaboration with local clinicians and colleagues in the USA, have identified a biomarker which is strongly associated with triple negative breast cancer (TNBC), a highly aggressive carcinoma that often has early relapse and metastasis following chemotherapy. The newly identified biomarker, a gene called RASAL2, provides a target for developing new therapeutics designed to treat this often deadly disease.

TNBC is deadly because, unlike other types of breast cancers such as estrogen receptor (ER) positive or HER2 amplified breast tumours which have effective targeted therapy, TNBC tumours do not respond to targeted therapy.

Breast cancer has many subtypes, each with its own genetic makeup. As such, different subtypes behave differently in invasion and metastasis. Using breast cancer cell lines and genomic data from patient samples, molecular biologist Min Feng and her colleagues at the GIS adopted an integrated approach to search for genes whose deregulation may help explain the high metastatic potential of TNBC cells.

Dr Feng found that a small RNA, often called microRNA, is lost in highly metastatic TNBC cells but not in luminal breast cancer. As a result, RASAL2, which is negatively regulated by this microRNA, is up-regulated in a set of TNBC tumours. The study showed that TNBC patients whose tumours have high expression of RASAL2 tend to have a lower survival rate as compared to patients whose tumours have low levels of this gene. Additionally, the study showed that genetic knockdown of RASAL2 gene can lead to reduced metastasis in breast cancer mouse model.

The findings were published recently in the Journal of Clinical Investigation (JCI).

Intriguingly, previous research found that RASAL2 was lost in some of the luminal type of breast tumours, where it acts as a tumour suppressor.

Project leader of the study, Prof Qiang Yu, Senior Group Leader of Cancer Therapeutics and Stratified Oncology Programme at the GIS, said, "Cancer is an extremely heterogeneous disease, where many molecular processes have gone wrong in their own ways. Rather than a tumour suppressor, we show here that RASAL2 actually acts as a cancer promoting molecule in TNBC. This reminds us that the same molecule can function very differently in different subtypes of cancers, a phenomenon which has often been seen before."

The study is the result of intensive collaboration with both local and international colleagues, including Dr Ern Yu Tan at Tan Tock Seng Hospital, Singapore, and Dr Dave Hoon at the John Wayne Cancer Institute in Santa Monica, California.

Dr Tan, a breast cancer doctor, said, "Therapeutic options remain limited and women with TNBC have a higher risk of disease relapse, with prognosis being generally poor after a relapse. With this finding, RASAL2 could be a new potential biomarker that is associated with the high risk of TNBC, rather than all types of breast tumours. This illustrates an important aspect of breast cancer biology. With a better understanding of the genetic makeup of tumours, it is now recognized that breast cancer comprises a diverse mix of tumours. This explains why not everyone with tumours of the same disease stage responds the same way to similar treatment."

GIS Executive Director Prof Huck Hui Ng, said, "The study is a reflection of an adaptation of our efforts towards translational research. We are working hard to build up an ecosystem to allow close collaborations between researchers and clinicians. Because the laboratory findings do not always replicate the 'real world' of human tumours, validation with samples derived from actual human tumours remains the 'final proof' of whether novel laboratory findings can be applied to clinical practice."

Prof Yu emphasised the necessity of further clinical validation for the study. He is also seeking industrial collaboration to develop diagnostic assays for high risk TNBC patients.

INFORMATION:

Notes to Editor:

The research findings described in the media release can be found in the Journal of Clinical Investigation, under the title, "RASAL2 activates RAC1 to promote triple negative breast cancer progression" by Min Feng1, Yi Bao1, Zhimei Li1, Juntao Li2, Min Gong1, Stella Lam3, Jinhua Wang3, Diego M. Marzese3, Nicholas Donovan3, Ern Yu Tan4, Dave S.B. Hoon3, and Qiang Yu1,5,6

1Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR, Biopolis, Singapore 138672
2Computational Biology, Genome Institute of Singapore, A*STAR, Biopolis, Singapore 138672
3Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, CA 90404
4Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433
5Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore 117597
6Cancer and Stem Cell Biology, DUKE-NUS Graduate Medical School of Singapore 169857

# Correspondence: yuq@gis.a-star.edu.sg

For media queries and clarifications, please contact:

Ms Winnie Lim
Head, Office of Corporate Communications
Genome Institute of Singapore, A*STAR
Tel: +65 6808 8013
Email: limcp2@gis.a-star.edu.sg

About the A*STAR's Genome Institute of Singapore (GIS)

The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. Established in 2000 as a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards academic, economic and societal impact.

The key research areas at the GIS include Human Genetics, Infectious Diseases, Cancer Therapeutics and Stratified Oncology, Stem Cell and Regenerative Biology, Cancer Stem Cell Biology, Computational and Systems Biology, and Translational Research.

The genomics infrastructure at the GIS is utilised to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact.

For more information about GIS, please visit: http://www.gis.a-star.edu.sg

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that fosters world-class scientific research and talent to drive economic growth and transform Singapore into a vibrant knowledge-based and innovation driven economy.

In line with its mission-oriented mandate, A*STAR spearheads research and development in fields that are essential to growing Singapore's manufacturing sector and catalysing new growth industries. A*STAR supports these economic clusters by providing intellectual, human and industrial capital to its partners in industry.

A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis, as well as their vicinity. These two R&D hubs house a bustling and diverse community of local and international research scientists and engineers from A*STAR's research entities as well as a growing number of corporate laboratories.

For more information about A*STAR, please visit: http://www.a-star.edu.sg



ELSE PRESS RELEASES FROM THIS DATE:

Genes and environment: Complex interactions at the heart of personalized medicine

2014-12-01
Personalized medicine uses methods of molecular analysis, especially genetic sequencing and transcription, in order to simultaneously identify genetic mutations to evaluate each individual's risk of contracting a given disease. It seems that there is more than a single mechanism at hand, as proven by the work of a team of geneticists at the University of Geneva's (UNIGE) Faculty of Medicine, and the Swiss Institute for Bioinformatics (SIB). They have sequenced the RNA of 400 pairs of twins; with this information, they can quantify the roles of both genetic and environmental ...

Taking the 'mute' off silenced gene may be answer to Angelman syndrome

2014-12-01
HOUSTON -- (Dec. 1, 2014) - Most genes are inherited as two working copies, one from the mother and one from the father. However, in a few instances, a gene is imprinted, which means that one copy is silenced. This is called genomic imprinting. If the active copy is mutated, then disease results, even though the silenced gene copy may be normal. Angelman syndrome, which causes learning difficulties, speech problems, seizures, jerky movements and an unusually happy disposition, results when a gene inherited from the mother in a particular area of chromosome 15 is mutated ...

Penn study points to new therapeutic strategy in chronic kidney disease

Penn study points to new therapeutic strategy in chronic kidney disease
2014-12-01
PHILADELPHIA-- Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease's progress towards kidney failure. Now, however, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania, has found an aspect of CKD's development that points to a promising new therapeutic strategy. "We found that a defect in energy production in affected kidney cells plays a key role in CKD development," says Katalin ...

Neuronal encoding of the switch from specific to generalized fear

2014-12-01
"I can't get the memories out of my mind!... I am right back in Vietnam, in the middle of the monsoon season at my guard post. My hands are freezing, yet sweat pours from my entire body...I smell a damp sulfur smell. Suddenly I see what's left of my buddy Troy, his head on a bamboo platter, sent back to our camp by the Viet Cong."i This veteran of the US army, who served in Vietnam, has intense flashbacks of his decapitated friend whenever he hears a clap of thunder, touches a bamboo mat, or sees an Oriental woman. Although the traumatic incident happened decades ago in ...

Scientists discover why bowel cancer sometimes outsmarts treatment

2014-12-01
A new study* that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine. Cancer Research UK scientists have discovered that bowel cancer may not be restricted to starting its journey in the stem cells in the lining of the intestines as previously thought. The researchers, based at the Wellcome Trust Centre for Human Genetics, studied a hereditary faulty gene which can cause bowel cancer in middle age. The faulty gene causes normal cells to behave like immortal stem cells and develop tumours of their ...

New research highlights the key role of ozone in climate change

2014-12-01
Many of the complex computer models which are used to predict climate change could be missing an important ozone 'feedback' factor in their calculations of future global warming, according to new research led by the University of Cambridge and published today (1 December) in the journal Nature Climate Change. Computer models play a crucial role in informing climate policy. They are used to assess the effect that carbon emissions have had on the Earth's climate to date, and to predict possible pathways for the future of our climate. Increasing computing power combined ...

Fighting malnutrition with a 'stronger' chickpea

2014-12-01
This news release is available in French. Micronutrient malnutrition affects more than 2 billion people. Researchers working at the Crop Development Centre at the University of Saskatchewan are seeking long term solutions to help to alleviate the increasing micronutrient malnutrition problem by enriching food grains with essential micronutrients through breeding and appropriate management practices, collectively known as biofortification. Chickpea (Cicer arietinum L.) is considered an excellent whole food as source of dietary proteins, carbohydrates, micronutrients ...

Study links sleep apnea to impaired exercise capacity

2014-12-01
DARIEN, IL - A new study shows that obstructive sleep apnea is associated with impaired exercise capacity, which is an indicator of increased cardiovascular risk. Results show that the predicted peak oxygen uptake, a measure of aerobic physical fitness, was significantly lower in people with moderate to severe obstructive sleep apnea than in controls. Further analysis found that sleep apnea severity alone explained 16.1 percent of this variability. "We found a significant association indicating that there is likely a very strong independent relationship between obstructive ...

Warning to bariatric surgery patients: Take your supplements, for eye's sake

2014-12-01
Obese patients who have undergone bariatric surgery to shed weight should take the supplements prescribed to them to protect their eyes. Taking in too little Vitamin A, in particular, could in some cases actually cause night blindness, dry eyes, corneal ulcers, and in extreme cases total blindness. This advice comes from Rui Azevedo Guerreiro and Rui Ribeiro of the Centro Hospitalar de Lisboa Central in Portugal, who reviewed what little research there currently is on the occurrence of eye conditions following bariatric surgery. The review is published in Springer's journal ...

Many people with missing teeth don't need dentures

2014-12-01
The latest research from the University of Adelaide challenges current thinking on whether many people with tooth loss really need dentures. The findings have major implications for public dental health resources and costs for patients. Studies conducted by the University's Australian Research Center for Population Oral Health in the School of Dentistry have found that people with tooth loss do not have their quality of life interfered with provided they still have a certain number and type of teeth left. In dentistry terms, these patients are considered to have "shortened ...

LAST 30 PRESS RELEASES:

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

[Press-News.org] Singapore scientists uncover gene associated with an aggressive breast cancer
Over-expressed gene in triple negative breast cancer offers new diagnostics for risk assessment